Lithium Induced Diabetes Insipidus: Prevention & Treatment
Lithium is considered the gold standard and first-line treatment for bipolar disorder and is known to have adverse effects on the kidney, thyroid, parathyroid, neurological and gastrointestinal systems. It is clinically relevant to have the knowledge on how to identify and manage these adverse events.
We have summarized the management of lithium’s adverse event in one of our lectures in the Bipolar Disorder Update 2020 online Conference.
Here is one of the slide from this lecture presentation, where Dr. Harvinder Singh has summarized the prevention and treatment options for lithium-induced diabetes insipidus:
CONFERENCE ENROLLMENT CLOSING ON DEC 5
CME CREDITS EXPIRING ON: DEC 14, 2021
JOIN NOW AT 20% DISCOUNT &
CLAIM 8.75 CME CREDITS
Psychiatry Education Forum continues to provide high-quality, practice-oriented evidence to improve your clinical decision-making. We are enthralled to release our second online CME conference. Once again, we guarantee that you will be accessing the most updated information for your invested time at a highly affordable cost.
Our second conference focuses exclusively on one of the most important aspects of your practice:
Managing Various Aspects of Bipolar Disorder.
CONFERENCE SCHEDULE
This conference contains ten lectures, which are divided in the following four sections:
(A) BIPOLAR DISORDER TREATMENT UPDATES
(1) Bipolar Depression: Management Update.
(Session Duration: 30 mins)
- Evidence for the efficacy of currently and commonly used treatments for bipolar depression.
- Review CANMAT recommendations for the treatment of bipolar depression.
- Role of antidepressant use in bipolar depression.
- Assess the data for new and emerging treatments for bipolar depression.
(2) Bipolar Mixed Specifier: Learn to Identify, Diagnose & Manage.
(Session Duration: 80 mins)
- Understanding the changes in DSM-5 mixed feature specifier compared to DSM-IV-TR mixed episode diagnosis.
- Why is diagnosing a mixed specifier clinically important?
- Which assessment scales can be used in your daily clinical practice?
- Management options for mixed features in bipolar disorder (including discussion of 20 treatment options)
(3) Treatment-Resistant Bipolar Disorder: Management Update.
(Session Duration: 60 mins)
- What is treatment resistance in bipolar disorder?
- Treatment options for treatment-resistant mania & depression for both acute and maintenance phases of bipolar disorder.
- Management of rapid cycling bipolar disorder.
- Understanding the suicide risk associated with bipolar disorder.
(B) BIPOLAR DISORDER IN SPECIAL POPULATIONS
(4) Bipolar Disorder Management During Pregnancy and Postpartum.
(Session Duration: 90 mins)
- Why worry about bipolar disorder in pregnancy and postpartum?
- Pre-conception planning & preparing patients for pregnancy in advance.
- Pharmacotherapy principles for bipolar disorder management (mania, hypomania & depression) during pregnancy & postpartum.
- Special Discussion Section on: Lithium, Lamotrigine & ECT.
- Breastfeeding & pharmacotherapy for bipolar disorder management.
(5) Bipolar Disorder Management in the Elderly.
(Session Duration: 45 mins)
- Is the presentation of bipolar disorder different in the elderly compared to young adults?
- Effects of bipolar disorder on cognitive functions in the elderly: Can bipolar disorder increase the risk of dementia?
- How bipolar disorder can affect psychosocial functioning in older adults?
- Potential pharmacotherapy treatment options for the management of the geriatric bipolar disorder.
- Role of lithium’s use in older adults with bipolar disorder.
(C) MANAGING MOOD STABILIZERS ADVERSE EVENTS
(6) Understanding Rashes Associated with Mood Stabilizers.
(Session Duration: 30 mins)
- Understanding the common and life-threatening rashes associated with mood stabilizers: SJS (Steven-Johnson Syndrome), TEN (Toxic Epidermal Necrolysis), and DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms).
- Which non-psychotropic medications to consider when rashes are seen with mood stabilizers?
- Understanding the risk factors and clinical courses of rashes: learning to identify life-threatening rashes early.
- Performing patient evaluation, diagnosis confirmation & assessment of drug casualty.
- Can we use the same class of medication again with a history of rash in past?
(7) Understanding Lithium's Adverse Events Management.
(Session Duration: 50 mins)
- Understanding the lithium’s adverse events on the kidney, thyroid, parathyroid, neurological, and gastrointestinal system.
- Discussing these adverse events in terms of the underlying mechanism, risk factors, clinical symptoms, laboratory evaluation, management, and guidelines for early identification/prevention.
(D) MANAGING BIPOLAR BEYOND PSYCHOPHARMACOLOGY
(8) How to Utilize Pharmacogenomic Testing in Treating Bipolar Disorder?
(Session Duration: 55 mins)
- Learning the key areas of evaluating & treating a patient with bipolar disorder utilizing genetic test results.
- Which patient population is a good candidate for including genetic testing in their treatment planning?
- Difference between laboratory genetic tests and over the counter consumer genetic tests.
- Learning the details of pharmacodynamic genes and applications of pharmacokinetic genetic results in the treatment of bipolar disorder.
- How to educate yourself on various genes implicated in psychiatric disorders?
(9) Impact of Cannabis on Managing Bipolar Disorder.
(Session Duration: 50 mins)
- Understanding cannabis pharmacology including THC & CBD.
- Why/How is the relationship between cannabis and bipolar disorder clinically important?
- Are there any potential benefits of using cannabis with bipolar disorder?
- Understanding the specific harms associated with cannabis use in bipolar disorder.
- Can cannabis cause the onset of bipolar disorder clinical features?
- How to best treat bipolar disorder with co-morbid cannabis use?
(10) The Biased Psychiatrist: How racial disparities affect the diagnosis and management of bipolar disorder?
(Session Duration: 45 mins)
- Reframing cultural competency education in medicine.
- Addressing initial practical steps in developing insight and working through our biases.
INTERESTED IN LEARNING MORE?
CME ACCREDITATIONS
8.75 AMA PRA Category 1 Credits Available
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and the Psychiatry Education Forum LLC. PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.
PeerPoint Medical Education Institute, LLC designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
